Samantha McClenahan

Program Lead l Program Head for De-risk Cytokine Release Syndrome

Fraunhofer Institute for Digital Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Samantha McClenahan is the Program Lead for De-risk Cytokine Release Syndrome at the Digital Medicine Society in the United States. Her research areas include sensor-based digital health technologies, pharmacokinetics, and the development of selective inhibitors for various potassium channels. Recent publications highlight her contributions to the analytical validation of digital health technologies and the implications of design and usability in health solutions.

Articles (9)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Maximilian Lyon

Assistant Professor

Saint Louis University

UNITED STATES

View details

Christopher Moore

Senior Lecturer

University of Wollongong

AUSTRALIA

View details

Changho Han

Vanderbilt University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Samantha McClenahan

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

A Hierarchical Framework for Selecting Reference Measures for the Analytical Validation of Sensor-Based Digital Health Technologies

Human Factors, Human-Centered Design, and Usability of Sensor-Based Digital Health Technologies: Scoping Review

Core elements of national policy for digital health technology evidence and access

Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B K<sub>ATP</sub> Channels.

A selective inhibitor of the sperm-specific potassium channel SLO3 impairs human sperm function

VU6036720: The first potent and selective in vitro inhibitor of heteromeric Kir4.1/5.1 inward rectifier potassium channels

Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy

Pharmacokinetics of α-Pyrrolidinovalerophenone in Male Rats with and without Vaccination with an α-Pyrrolidinovalerophenone Vaccine.

Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine.

Collaborators (3)

Maximilian Lyon

Christopher Moore

Changho Han

Make your next move.